Mason Capital Management’s Sanofi Contingent Value Rights GCVRZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-14,644,398
| Closed | -$12.6M | – | 13 |
|
|
2019
Q4 | $12.6M | Hold |
14,644,398
| – | – | 4.32% | 6 |
|
|
2019
Q3 | $8.2M | Hold |
14,644,398
| – | – | 2% | 6 |
|
|
2019
Q2 | $7.62M | Hold |
14,644,398
| – | – | 1.45% | 9 |
|
|
2019
Q1 | $6.59M | Hold |
14,644,398
| – | – | 1.42% | 7 |
|
|
2018
Q4 | $7.03M | Hold |
14,644,398
| – | – | 0.27% | 12 |
|
|
2018
Q3 | $7.76M | Hold |
14,644,398
| – | – | 0.45% | 16 |
|
|
2018
Q2 | $7.32M | Hold |
14,644,398
| – | – | 0.26% | 22 |
|
|
2018
Q1 | $6.15M | Hold |
14,644,398
| – | – | 0.28% | 20 |
|
|
2017
Q4 | $5.57M | Hold |
14,644,398
| – | – | 0.34% | 16 |
|
|
2017
Q3 | $5.27M | Hold |
14,644,398
| – | – | 0.17% | 21 |
|
|
2017
Q2 | $5.57M | Hold |
14,644,398
| – | – | 0.36% | 22 |
|
|
2017
Q1 | $6.59M | Hold |
14,644,398
| – | – | 0.42% | 16 |
|
|
2016
Q4 | $5.57M | Hold |
14,644,398
| – | – | 0.29% | 25 |
|
|
2016
Q3 | $3.95M | Hold |
14,644,398
| – | – | 0.34% | 18 |
|
|
2016
Q2 | $3.52M | Hold |
14,644,398
| – | – | 0.11% | 18 |
|
|
2016
Q1 | $1.61M | Hold |
14,644,398
| – | – | 0.05% | 19 |
|
|
2015
Q4 | $1.61M | Hold |
14,644,398
| – | – | 0.05% | 18 |
|
|
2015
Q3 | $2.78M | Hold |
14,644,398
| – | – | 0.06% | 19 |
|
|
2015
Q2 | $10.3M | Hold |
14,644,398
| – | – | 0.18% | 24 |
|
|
2015
Q1 | $9.96M | Hold |
14,644,398
| – | – | 0.17% | 27 |
|
|
2014
Q4 | $11.6M | Sell |
14,644,398
-407,381
| -3% | -$278K | 0.27% | 20 |
|
|
2014
Q3 | $7.07M | Hold |
15,051,779
| – | – | 0.07% | 47 |
|
|
2014
Q2 | $7.53M | Hold |
15,051,779
| – | – | 0.09% | 42 |
|
|
2014
Q1 | $4.67M | Hold |
15,051,779
| – | – | 0.1% | 26 |
|
|
2013
Q4 | $5.12M | Buy |
15,051,779
+3,459,862
| +30% | +$4.18M | 0.09% | 28 |
|
|
2013
Q3 | $23.4M | Buy |
11,591,917
+3,143,258
| +37% | +$5.99M | 0.44% | 29 |
|
|
2013
Q2 | $16.1M | Buy |
+8,448,659
| New | +$14.8M | 0.32% | 29 |
|
Mason Capital Management's GCVRZ Position: Q1 2020 in Review
Mason Capital Management sold out of Sanofi Contingent Value Rights (GCVRZ) in Q1 2020, closing a stake of 14,644,398 shares — an estimated $12.6M sold.
Mason Capital Management first reported a position in GCVRZ in Q2 2013 and held it in 27 quarters. The position peaked at $23.4M in Q3 2013. 2 funds tracked by Wall St. Rank hold GCVRZ as of Q1 2020.
- Mason Capital Management reported no remaining Sanofi Contingent Value Rights position as of Q1 2020 after selling out during the quarter.
- Mason Capital Management sold 14,644,398 Sanofi Contingent Value Rights shares in Q1 2020, an estimated $12.6M.
- Mason Capital Management first reported a position in Sanofi Contingent Value Rights in Q2 2013 and held it in 27 quarters.
- Mason Capital Management's Sanofi Contingent Value Rights position peaked at $23.4M in Q3 2013.
- 2 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q1 2020.
Based on Mason Capital Management's 13F filing for Q1 2020, filed 15 May 2020.